UK biotech AKL Research and Development (AKLRD) has received a grant from a UK government-backed innovation body to develop its potentially “game changing” osteoarthritis drug.
The UK Government’s innovation agency Innovate UK has awarded AKL Research and Development (AKLRD) £675,000 linked to the potential of its investigational medicine APPA for osteoarthritis......